# Ulcerative Colitis

## Length of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medications not requiring prior approval
-   Contraindication to or drug interaction with medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Information

1.  Ulcerative Colitis Agents are available in both oral (IR, ER) and rectal (enema, suppository) formulations. Patients with mild or moderate disease may be treated with either rectal or oral agents.
2.  The efficacy among the different 5-ASA derivatives appears to be comparable.

For a non-preferred agent, there must have been inadequate clinical response to preferred alternatives, including a trial of no less than **30 days each** of at least **two** preferred products.

Budesonide ER 9mg tablet quantity limit of 56 tablets per 90 days

## Formulary

Gastrointestinal Agents: Ulcerative Colitis

### Preferred

| Preferred            |      |
| :------------------- | ---: |
| Balsalazide Disodium |      |
| Budesonide ER Tab QL |      |
| Lialda BvG           |      |
| Mesalamine DR Cap    |      |
| Mesalamine Enema     |      |
| Mesalamine ER        |      |
| Pentasa BvG          |      |
| Sulfasalazine        |      |

### Non-Preferred

| Non-Preferred     |      |
| :---------------- | ---: |
| Dipentum          |      |
| Mesalamine DR Tab |      |
| Mesalamine Supp   |      |
| Uceris Foam       |      |
| Zeposia           |      |

## Links

[Criteria]https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=66)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=23)
